v3.26.1
Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Statement of Comprehensive Income [Abstract]        
Net earnings $ 3,616 $ 941 $ 4,313 $ 2,230
Foreign currency translation adjustments, net of tax expense (benefit) of $(2) for the three months and $(7) for the six months ended June 30, 2026 and $33 for the three months and $50 for the six months ended June 30, 2025 (144) 1,051 (348) 1,538
Net investment hedging activities, net of tax expense (benefit) of $21 for the three months and $64 for the six months ended June 30, 2026 and $(192) for the three months and $(269) for the six months ended June 30, 2025 76 (698) 232 (981)
Pension and post-employment benefits, net of tax expense (benefit) of $2 for the three and six months ended June 30, 2026 and $— for the three and six months ended June 30, 2025 0 4 (1) 2
Cash flow hedging activities, net of tax expense (benefit) of $4 for the three and six months ended June 30, 2026 and $(16) for the three months and $(20) for the six months ended June 30, 2025 63 (153) 103 (172)
Other comprehensive income (loss) (5) 204 (14) 387
Comprehensive income 3,611 1,145 4,299 2,617
Comprehensive income attributable to noncontrolling interest 3 3 5 6
Comprehensive income attributable to AbbVie Inc. $ 3,608 $ 1,142 $ 4,294 $ 2,611